The diagnostic value of CSF α-synuclein in the differential diagnosis of dementia with Lewy bodies vs. normal subjects and patients with Alzheimer's disease.
The detection of α-synuclein (α-syn) in the cerebrospinal fluid (CSF) of patients with synucleinopathy has yielded promising but inconclusive results. The aim of the present study was to determine the diagnostic value of α-syn as a biological marker for Dementia with Lewy bodies (DLB) vs. normal sub...
Enregistré dans:
Auteurs principaux: | Elisabeth Kapaki, George P Paraskevas, Evangelia Emmanouilidou, Kostas Vekrellis |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2013
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/bb56ccd77ed743bdac5b93a27a196afd |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Altered serum IgG levels to α-synuclein in dementia with Lewy bodies and Alzheimer's disease.
par: Niklas K U Koehler, et autres
Publié: (2013) -
α-Synuclein-mediated neurodegeneration in Dementia with Lewy bodies: the pathobiology of a paradox
par: Christopher Simon, et autres
Publié: (2021) -
Advances in dementia with Lewy bodies
par: Melissa J. Armstrong
Publié: (2021) -
Cognitive fluctuations in connection to dysgraphia: a comparison of Alzheimer’s disease with dementia Lewy bodies
par: Onofri E, et autres
Publié: (2015) -
Demography, diagnostics, and medication in dementia with Lewy bodies and Parkinson's disease with dementia: data from the Swedish Dementia Quality Registry (SveDem)
par: Fereshtehnejad SM, et autres
Publié: (2013)